Simplex Trading’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $823K | Buy |
4,200
+1,200
| +40% | +$233K | ﹤0.01% | 2700 |
|
|
2025
Q4 | $521K | Sell |
3,000
-8,000
| -73% | -$1.46M | ﹤0.01% | 3266 |
|
|
2025
Q3 | $2.1M | Buy |
11,000
+400
| +4% | +$71K | ﹤0.01% | 2280 |
|
|
2025
Q2 | $1.9M | Buy |
10,600
+400
| +4% | +$69.5K | ﹤0.01% | 2160 |
|
|
2025
Q1 | $1.73M | Buy |
10,200
+5,700
| +127% | +$936K | ﹤0.01% | 2180 |
|
|
2024
Q4 | $678K | Sell |
4,500
-3,600
| -44% | -$560K | ﹤0.01% | 3234 |
|
|
2024
Q3 | $1.26M | Sell |
8,100
-21,900
| -73% | -$3.27M | ﹤0.01% | 2704 |
|
|
2024
Q2 | $4.11M | Sell |
30,000
-5,100
| -15% | -$698K | ﹤0.01% | 1581 |
|
|
2024
Q1 | $4.67M | Buy |
35,100
+7,800
| +29% | +$1.01M | ﹤0.01% | 1653 |
|
|
2023
Q4 | $3.76M | Sell |
27,300
-60,100
| -69% | -$7.9M | ﹤0.01% | 1800 |
|
|
2023
Q3 | $10.7M | Buy |
87,400
+47,700
| +120% | +$6.36M | 0.01% | 895 |
|
|
2023
Q2 | $5.58M | Buy |
39,700
+9,000
| +29% | +$1.24M | ﹤0.01% | 1243 |
|
|
2023
Q1 | $4.34M | Sell |
30,700
-10,000
| -25% | -$1.43M | ﹤0.01% | 1387 |
|
|
2022
Q4 | $6.37M | Buy |
40,700
+34,700
| +578% | +$4.99M | 0.01% | 1088 |
|
|
2022
Q3 | $736K | Buy |
6,000
+1,300
| +28% | +$171K | ﹤0.01% | 3015 |
|
|
2022
Q2 | $625K | Sell |
4,700
-20,100
| -81% | -$2.74M | ﹤0.01% | 3178 |
|
|
2022
Q1 | $3.39M | Sell |
24,800
-17,100
| -41% | -$2.38M | ﹤0.01% | 1587 |
|
|
2021
Q4 | $7.25M | Buy |
41,900
+13,200
| +46% | +$2.01M | 0.01% | 976 |
|
|
2021
Q3 | $3.81M | Buy |
28,700
+200
| +0.7% | +$29.3K | ﹤0.01% | 1446 |
|
|
2021
Q2 | $3.76M | Buy |
28,500
+28,388
| +25,346% | +$3.72M | ﹤0.01% | 1449 |
|
|
2021
Q1 | $1.44M | Sell |
112
-34
| -23% | -$4.19K | ﹤0.01% | 1996 |
|
|
2020
Q4 | $1.74M | Sell |
146
-169
| -54% | -$20.6K | ﹤0.01% | 1916 |
|
|
2020
Q3 | $3.61M | Sell |
315
-104
| -25% | -$12.3K | ﹤0.01% | 1080 |
|
|
2020
Q2 | $4.77M | Sell |
419
-157
| -27% | -$16.7K | 0.01% | 876 |
|
|
2020
Q1 | $4.63M | Buy |
576
+374
| +185% | +$38.7K | 0.01% | 734 |
|
|
2019
Q4 | $2.16M | Sell |
202
-73
| -27% | -$7.61K | ﹤0.01% | 1410 |
|
|
2019
Q3 | $2.94M | Sell |
275
-160
| -37% | -$16.4K | 0.01% | 1037 |
|
|
2019
Q2 | $4.43M | Buy |
435
+342
| +368% | +$32.9K | 0.01% | 742 |
|
|
2019
Q1 | $836K | Sell |
93
-111
| -54% | -$9.62K | ﹤0.01% | 2151 |
|
|
2018
Q4 | $1.7M | Buy |
204
+14
| +7% | +$1.31K | 0.01% | 1206 |
|
|
2018
Q3 | $2.05M | Buy |
190
+142
| +296% | +$15.6K | 0.01% | 1234 |
|
|
2018
Q2 | $527K | Buy |
48
+28
| +140% | +$2.92K | ﹤0.01% | 2416 |
|
|
2018
Q1 | $2K | Sell |
20
-62
| -76% | -$6.35K | ﹤0.01% | 5226 |
|
|
2017
Q4 | $24K | Sell |
82
-26
| -24% | -$2.46K | ﹤0.01% | 3123 |
|
|
2017
Q3 | $6K | Buy |
108
+74
| +218% | +$7.86K | ﹤0.01% | 4215 |
|
|
2017
Q2 | $11K | Sell |
34
-366
| -92% | -$38.7K | ﹤0.01% | 3875 |
|
|
2017
Q1 | $48K | Buy |
400
+356
| +809% | +$33.9K | ﹤0.01% | 2410 |
|
|
2016
Q4 | $21K | Sell |
44
-92
| -68% | -$7.93K | ﹤0.01% | 2991 |
|
|
2016
Q3 | $28K | Buy |
136
+51
| +60% | +$4.28K | ﹤0.01% | 2626 |
|
|
2016
Q2 | $32K | Buy |
85
+1
| +1% | +$76 | ﹤0.01% | 2456 |
|
|
2016
Q1 | $55K | Buy |
84
+3
| +4% | +$201 | ﹤0.01% | 1880 |
|
|
2015
Q4 | $27K | Buy |
81
+49
| +153% | +$3.29K | ﹤0.01% | 2439 |
|
|
2015
Q3 | $6K | Sell |
32
-39
| -55% | -$2.73K | ﹤0.01% | 3828 |
|
|
2015
Q2 | $24K | Buy |
71
+47
| +196% | +$3.47K | ﹤0.01% | 2297 |
|
|
2015
Q1 | $29K | Buy |
24
+11
| +85% | +$788 | ﹤0.01% | 1994 |
|
|
2014
Q4 | $11K | Buy |
+13
| New | +$820 | ﹤0.01% | 2517 |
|
Other funds holding DGX
VCM
VPM
EIG
Simplex Trading's DGX Position: Q1 2026 in Review
Simplex Trading reduced its Quest Diagnostics (DGX) stake by 88% in Q1 2026, selling an estimated $847K and leaving 596 shares worth $117K. The position accounts for ﹤0.01% of the portfolio, ranked #4905.
Simplex Trading first reported a position in DGX in Q3 2015 and has held it in 23 quarters since. The position peaked at $1.88M in Q1 2024. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- Simplex Trading held 596 shares of Quest Diagnostics worth $117K as of Q1 2026.
- Simplex Trading sold 4,362 Quest Diagnostics shares in Q1 2026, an estimated $847K.
- Quest Diagnostics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4905 holding.
- Simplex Trading first reported a position in Quest Diagnostics in Q3 2015 and has held it in 23 quarters since.
- Simplex Trading's Quest Diagnostics position peaked at $1.88M in Q1 2024.
- 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.